News Category
Medical device companies Impulse Dynamics NV and MetaCure Ltd. have announced today the signing of a strategic Asia-Pacific distribution agreement with newly formed Australian company Vitality Devices Pty. Ltd. Australia (PRWEB) February 21, 2012 Under this agreement Vitality will distribute Impulse Dynamics’ OPTIMIZER System for treating Chronic Heart Failure (CHF) and MetaCure’s DIAMOND System for [...]
Read More
DIAMOND System featured in the japanese show “the world’s astonishing news” discussing treatments for diabetes and obesity.
Read More
The favorable Benefit-Risk profile of the DIAMOND (TANTALUS) System , a minimally invasive gastric stimulator for treatment of Type 2 Diabetes and its metabolic comorbidities, developed by MetaCure, was presented at the Annual Meeting of the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) in Hamburg at the beginning of September. Prof. [...]
Read More
A Sweet Life blog article, May 31, 2011 With today’s growing type 2 diabetes epidemic, there’s a need for new ways to treat the disease. Not everyone achieves good glycemic control with oral medications and some medications, like insulin, lead to weight gain. For type 2 diabetics who also suffer from obesity, any treatment that [...]
Read More
The article, published on April 18th on “The Gray Sheet” reveals the Company’s plans to wrap up three overseas trials by the end of 2012 for its DIAMOND electrostimulator implant for type 2 diabetes in obese patients and begin a pivotal U.S. trial within the next couple of years to support a PMA submission for [...]
Read More
The DIAMOND (TANTALUS) System, a minimally invasive gastric stimulation System for Treatment of Type 2 Diabetes developed by MetaCure was found to have a desirable long term safety profile. Safety is a crucial point in Type 2 Diabetes treatments in light of the recent safety concerns regarding some antidiabetic agents and the associated risk and [...]
Read More
In a poster presented at the 2nd World Congress on Interventional Therapies for Type 2 Diabetes held in New York on March 28-30, Dr. Simon Wong from the Department of Surgery at Prince of Wales Hospital in The Chinese University of Hong Kong demonstrated that as compared to insulin therapy, the DIAMOND System has the [...]
Read More
Surgery should be considered earlier in the treatment of eligible patients to help stem the serious complications that can result from diabetes, according to an International Diabetes Federation (IDF) position statement presented at the 2nd World Congress on Interventional Therapies for Type 2 Diabetes in New York. Read full article on Internal Medicine News Visit [...]
Read More
MailOnline Article, March 29, 2011 A pacemaker-style device that delivers mild electric pulses to the stomach could be a new way to tackle type-2 diabetes, the most common form of the disease. The matchbox-sized gadget, implanted under the skin on the abdomen, stimulates the stomach muscles when the patient is eating. Studies show this boost in [...]
Read More
Interventional Diabetology is recognized as a cutting edge paradigm for treatment of Type 2 Diabetes. The TANTALUS gastric stimulator System, regarded as the first CE approved Interventional Diabetology device, was developed by MetaCure, to treat the Type 2 Diabetic and obese population. TANTALUS significantly improves glycemic control, blood pressure and lipid profile while inducing moderate [...]
Read More
